gentian violet has been researched along with Prostatic Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves, TM; Cordell, GA; Ribeiro, A; Romanha, AJ; Scio, E; Shin, YG; Zani, CL | 1 |
Carty, MP; Claffey, J; Cuffe, S; Dowling, CM; Fitzpatrick, JM; Hogan, M; Pampillón, C; Tacke, M; Watson, RW | 1 |
Kumagai, T; Shimizu, T; Takeda, K; Tomari, K | 1 |
Ochel, HJ | 1 |
Chang, SM; Chung, LW; Degeorges, A; Ozen, M; Pathak, S; Sikes, RA; Thalmann, GN; Wu, TT | 1 |
Burt, H; Gleave, ME; Jackson, J; Leung, SY; Miyake, H | 1 |
6 other study(ies) available for gentian violet and Prostatic Neoplasms
Article | Year |
---|---|
New bioactive coumarins from Kielmeyera albopunctata.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brazil; Chagas Disease; Clusiaceae; Coumarins; Humans; KB Cells; Lung Neoplasms; Male; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Bark; Plant Stems; Plants, Medicinal; Prostatic Neoplasms; Trypanocidal Agents; Trypanosoma cruzi; Tumor Cells, Cultured | 2003 |
Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Gentian Violet; Humans; Male; Neoplasms, Hormone-Dependent; Organometallic Compounds; Prostatic Neoplasms; Titanium | 2011 |
Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Topics: Androgens; Blotting, Northern; Blotting, Western; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Dihydrotestosterone; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Gentian Violet; Humans; Male; Phosphorylation; Prostatic Neoplasms; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Time Factors; Transcription Factors; Transforming Growth Factor beta; Up-Regulation | 2005 |
Correlation between crystal violet dissolution assay and manual colony counting on the in vitro effects of Hsp90-inhibitors.
Topics: Cell Line, Tumor; Coloring Agents; Drug Screening Assays, Antitumor; Gentian Violet; HSP90 Heat-Shock Proteins; Humans; Male; Observer Variation; Prostatic Neoplasms; Radiation Dosage; Reproducibility of Results; Solubility; Tumor Stem Cell Assay | 2005 |
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Topics: Animals; Blotting, Northern; Bone Neoplasms; Cell Line; Dihydrotestosterone; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gentian Violet; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Karyotyping; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Orchiectomy; Osteosarcoma; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Neoplasm; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 2000 |
Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Electrophoresis, Agar Gel; Gentian Violet; Humans; Immunoenzyme Techniques; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Orchiectomy; Paclitaxel; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2000 |